Company / Operating Income per Share
PULSE BIOSCIENCES, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.17
FY2025
5-year range
-$2.47 / -$1.02
FY2021-FY2025
Trend
-14.4%
vs FY2024
Sector context
#124 of 154
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s operating income per share of $-1.17 is lower than 81% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.47 in FY2021 to $-0.86 in FY2016.
Based on SEC 10-K filings.
-1.17 in FY2025.
Improved from $-1.56 to $-1.17 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 154This company -$1.17 Sector average $4.25
▼
-127.4% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 14.4% year-over-year.
- Ranks #124 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.17 | -14.4% |
| FY2024 | -$1.02 | +34.6% |
| FY2023 | -$1.56 | +20.2% |
| FY2022 | -$1.95 | +20.8% |
| FY2021 | -$2.47 | -14.8% |
| FY2020 | -$2.15 | +7.0% |
| FY2019 | -$2.31 | -5.1% |
| FY2018 | -$2.20 | -26.9% |
| FY2017 | -$1.73 | -100.4% |
| FY2016 | -$0.86 | -46.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026